LEAP
In March 2024, LEAP unveiled an innovative holographic experience for Novo Nordisk that was presented at the 22nd Panhellenic Diabetes Congress. This immersive presentation featured two patient profiles, each elucidated through six interactive slides. Attendees explored detailed medical data, observed treatment progress, and analyzed supporting charts. The holographic experience not only showcased individual patient journeys but also highlighted Novo Nordisk’s commitment to innovative diabetes care solutions.